Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
The broad objective of the Opportunities Fund Management Core (OFMC) will be to facilitate early stage
support for innovative, exploratory, and R&D projects, particularly those which have the potential to lead to
practical products in the fields of radiation biodosimetry and prediction and prevention of acute and delayed
injuries. The OFMC will support 1) Pilot projects (basic and translational research) and 2) Advanced
Development projects that lead to Investigational New Drug (IND)-enabling studies and Medical
Countermeasure (MCM) development.
The OFMC will generate an SOP (Standard Operating Procedure) for the operation of the Core, which after
Steering Committee approval, will be the template for its operation. The OFMC will coordinate the process of
soliciting proposals, as well as coordinating the review of the proposals by an external panel of experts
convened via teleconference for the purpose. The OFMC will tally the scores given by the review panel at the
teleconference, and present the rank ordered list to the Steering Committee for funding decisions.
Innovative and translational research will be strongly emphasized in the review process. The OFMC will
also be responsible for coordinating all necessary documentation of financial, IRB, and IACUC requirements
with sub-recipient institutions, as well as financial oversight and reporting. The OFMC will also coordinate
annual progress reports, and collect progress reports with renewal requests to be considered by the Steering
Committee. The OFMC will also help to facilitate Presentation opportunities for the pilot project recipients. For
instance, pilot awardees may be given the opportunity to prepare a poster for the annual CMCRC meeting, and
will be encouraged to present at national meetings, such as the Radiation Research Society Annual Meeting.
!
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcuteAdvanced DevelopmentAdvertisingAwardBasic ScienceCollaborationsCommunicationDevelopmentDocumentationFundingFunding OpportunitiesIACUCInjuryInstitutionInstitutional Review BoardsInvestigational DrugsPilot ProjectsPreventionProceduresProcessProgress ReportsRadiationRadiation InjuriesReportingResearchRoleSocietiesTeleconferencesTranslational ResearchUnited States National Institutes of HealthUpdatebiodosimetrydata sharinginnovationmedical countermeasuremeetingsminimally invasiveoperationoutreachpostersprogramsrecruitresearch and developmentweb page
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
31-August-2005
Project End Date
13-March-2025
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$3,173,725
Direct Costs
$2,781,929
Indirect Costs
$391,796
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$3,173,725
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U19AI067773-20 5848
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U19AI067773-20 5848
Patents
No Patents information available for 5U19AI067773-20 5848
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U19AI067773-20 5848
Clinical Studies
No Clinical Studies information available for 5U19AI067773-20 5848
News and More
Related News Releases
No news release information available for 5U19AI067773-20 5848
History
No Historical information available for 5U19AI067773-20 5848
Similar Projects
No Similar Projects information available for 5U19AI067773-20 5848